SPDR S&P Biotech ETF (NYSEARCA:XBI) Position Cut by Millrace Asset Group Inc.

Millrace Asset Group Inc. reduced its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 32,847 shares of the exchange traded fund’s stock after selling 2,165 shares during the period. SPDR S&P Biotech ETF comprises about 3.3% of Millrace Asset Group Inc.’s holdings, making the stock its largest holding. Millrace Asset Group Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,245,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $141,284,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of SPDR S&P Biotech ETF by 1.6% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after acquiring an additional 18,202 shares in the last quarter. Jane Street Group LLC grew its stake in SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after purchasing an additional 391,333 shares in the last quarter. Mirae Asset Securities USA Inc. increased its holdings in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the period. Finally, Employees Retirement System of Texas raised its position in SPDR S&P Biotech ETF by 40.8% in the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after purchasing an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 1.4 %

Shares of NYSEARCA:XBI opened at $97.63 on Tuesday. The company has a market cap of $7.44 billion, a PE ratio of 11.47 and a beta of 1.11. The company’s 50 day moving average is $98.37 and its two-hundred day moving average is $96.38. SPDR S&P Biotech ETF has a 52 week low of $71.99 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.